MedPath

University of Virginia

University of Virginia logo
🇺🇸United States
Ownership
Private
Established
1819-01-01
Employees
10K
Market Cap
-
Website
http://www.virginia.edu

New Treatment for Alcohol and Nicotine Dependence

Phase 2
Conditions
Alcohol Dependence
Nicotine Dependence
Interventions
Drug: Placebo with brief behavioral enhancement therapy
First Posted Date
2010-08-17
Last Posted Date
2022-05-09
Lead Sponsor
University of Virginia
Target Recruit Count
294
Registration Number
NCT01182766
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

University of California, San Diego, La Jolla, California, United States

🇺🇸

University of Virginia Center for Addiction Research & Education, Richmond, Virginia, United States

Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction

Phase 4
Completed
Conditions
Anesthesia Intubation Complication
Interventions
First Posted Date
2010-06-28
Last Posted Date
2021-02-08
Lead Sponsor
University of Virginia
Target Recruit Count
106
Registration Number
NCT01150838
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Classroom-Level Intervention to Promote Peers' Acceptance of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Behavioral: Behavioral contingency management
Behavioral: Tolerance training
First Posted Date
2010-05-28
Last Posted Date
2010-05-28
Lead Sponsor
University of Virginia
Target Recruit Count
102
Registration Number
NCT01133028
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Improved Detection of Neonatal Sepsis Using a Targeted Biomarker Assay

Completed
Conditions
Neonatal Sepsis
First Posted Date
2010-05-11
Last Posted Date
2020-11-04
Lead Sponsor
University of Virginia
Target Recruit Count
250
Registration Number
NCT01120678
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

🇺🇸

University of Virginia Neonatal Intensive Care Unit, Charlottesville, Virginia, United States

The Effects of Gentle Movements at the Ankle in Individuals With Diminished Range of Motion

Not Applicable
Conditions
Lateral Ankle Sprain
Interventions
Other: Sham ("laying of hands") intervention
Other: Grade IV AP joint mobilizations
First Posted Date
2010-05-07
Last Posted Date
2011-05-30
Lead Sponsor
University of Virginia
Target Recruit Count
40
Registration Number
NCT01119092
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Effects of Talocrural Joint Mobilizations in the Treatment of Subacute Lateral Ankle Sprains

Not Applicable
Conditions
Ankle Sprain
Interventions
Other: Sham intervention
Other: Mobilization therapy in addition to standard therapy
First Posted Date
2010-05-06
Last Posted Date
2011-05-30
Lead Sponsor
University of Virginia
Target Recruit Count
60
Registration Number
NCT01117909
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

Not Applicable
Terminated
Conditions
Type 2 Diabetes
Interventions
Drug: ACEI or ARB
First Posted Date
2010-04-09
Last Posted Date
2017-05-12
Lead Sponsor
University of Virginia
Target Recruit Count
6
Registration Number
NCT01101269
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Ultrasound Assessment During Exercise

Not Applicable
Completed
Conditions
Low Back Pain
Interventions
Other: Exercise
Other: Core stability exercise
First Posted Date
2009-11-18
Last Posted Date
2009-11-18
Lead Sponsor
University of Virginia
Target Recruit Count
80
Registration Number
NCT01015846
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Device: Closed-Loop, Model Predictive Control (MPC)
Device: Open-Loop
First Posted Date
2009-09-16
Last Posted Date
2014-09-04
Lead Sponsor
University of Virginia
Target Recruit Count
12
Registration Number
NCT00977808
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Neurodevelopmental Outcomes and Fluconazole Prophylaxis

Completed
Conditions
Neurodevelopmental Outcomes
Interventions
Other: Survey
First Posted Date
2009-09-14
Last Posted Date
2013-01-15
Lead Sponsor
University of Virginia
Target Recruit Count
39
Registration Number
NCT00975949
Locations
🇺🇸

University of Virginia Neonatal Intensive Care Unit, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath